Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes

Japanese Journal of Neuropsychopharmacology

Volumn 25, Issue 3, 2005, Pages 143-151

  Yasui, Mitsuru ^a   Kato, Akira ^a   Kanemasa, Toshiyuki ^a   Murata, Shunji ^a   Nishitomi, Kohei ^a   Koike, Katsumi ^a   Tai, Nobuyuki ^a   Shinohara, Shunji ^a   Tokumura, Miwa ^a   Horiuchi, Masahito ^a   Abe, Kohji ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

1; 2; Benzodiazepine receptor; Hypnotic effect; Motor incoordination

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE RECEPTOR OMEGA; BENZODIAZEPINE RECEPTOR OMEGA 1; BENZODIAZEPINE RECEPTOR OMEGA 2; BROTIZOLAM; HYPNOTIC AGENT; NITRAZEPAM; QUAZEPAM; RECEPTOR SUBTYPE; RILMAZAFONE; THIOPENTAL; UNCLASSIFIED DRUG; ZOLPIDEM; ZOPICLONE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; HYPNOSIS; MAZE TEST; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; ROTAROD TEST; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HYPNOTICS AND SEDATIVES; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; THIOPENTAL; TIME FACTORS;

EID: 22544452712     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 3H] zolpidem binding in the rat brain: An imidazopyridine with agonist properties at central benzodiazepine receptors. Eur J Pharmacol, 130: 257-263
2. Barthokini, G. (1988) Growing aspects of hypnotic drugs. In Sauvanet, J. P., Langer, S. Z. and Morselli, P. L. (Eds), Imidazopyridines and Sleep Disorders. Raven Press, New York, pp 1-9.
3. Bellemann, P. (1980) Primary monolayer culture of liver parenchymal cells and kidney cortical tubules as a useful new model for biochemical pharmacology and experimental toxicology. Studies in vitro on hepatic membrane transport, induction of liver enzymes, and adaptive changes in renal cortical enzymes. Arch Toxicol, 44: 63-84.
4. Corda, M. G., Sanna, E., Concas, A., Giorgi, O., Ongini, E., Nurchi, V., Pintori, T., Crisponi, G. and Biggio, G. (1986) Enhancement of γ-aminobutyric acid binding by quazepam, a benzodiazepine derivative with preferential affinity for type I benzodiazepine receptors. J Neurochem, 47: 370-374.
5. A receptors and benzodiazepines: A role for dendritic resident subunit mRNAs. Neuropharmacology, 43: 925-937.
6. 3H] zolpidem. J Pharmacol Exp Ther, 247: 309-322.
7. Depoortere, H., Zivkovic, B., Lloyd, K. G., Sanger, D. J., Perrault, G., Langer, S. Z. and Barthokini, G. (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther, 237: 649-658.
8. 1) selective, benzodiazepine receptor ligands in murine models of "state" and "trait" anxiety. Neuropharmacology, 35: 1081-1091.
9. Heel, R. C., Brogden, R. N., Speight, T. M. and Avery, G. S. (1981) Temazepam: A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs, 21: 321-340.
10. Jonas, J. M., Coleman, B. S., Sheridan, A. Q. and Kalinske, R. W. (1992) Comparative clinical profiles of triazolam versus other shorter-acting hypnotics. J Clin Psychiatry, 53 (Suppl): 19-33.
11. Klepner, C. A., Lippa, A. S., Benson, D. I., Sano, M. C. and Beer, B. (1979) Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors. Pharmacol Biochem Behav, 11: 457-462.
12. Langtry, H. D. and Benfield, P. (1990) Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs, 40: 291-313.
13. Lister, R. G. (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology, 92: 180-185.
14. Löw, K., Crestani, F., Keist, R., Benke, D., Brunig, I., Benson, J. A., Fritschy, J. M., Rülicke, T., Bluethmann, H., Möhler, H. and Rudolph, U. (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science, 290: 131-134.
15. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J Biol Chem, 193: 265-275.
16. 1 subtype. Nature Neurosci, 3: 587-592.
17. Munson, P. J. and Rodbard, D. (1980) LIGANO: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem, 107: 220-239.
18. 3H]flunitrazepam binding sites. J Neurochem, 49: 890-899.
19. A/benzodiazepine receptor complex in the rat nervous system. J Neurochem, 58: 485-493.
20. A receptor subtypes. Nature, 401: 796-800.
21. A receptor sub-types: Dissecting their pharmacological functions. Trends Pharmacol Sci, 22: 188-194.
22. 3H] Ro5-4864 in rat brain and kidney. J Pharmacol Exp Ther, 225: 61-69.
23. Sieghart, W. (1995) Structure and pharmacology of γ-aminobutyric acid A receptor subtypes. Pharmacol Rev, 47: 181-234.
24. Squires, R. F., Benson, D. I., Braestrup, C., Coupet, J., Klepner, C. A., Myers, V. and Beer, B. (1979) Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors. Pharmacol Biochem Behav, 10: 825-830.